These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7502514)

  • 21. The effect of long-term treatment with hypotensive drugs on blood viscosity and erythrocyte deformability in patients with essential arterial hypertension.
    Martínez M; Vayá A; Labios M; Gabriel F; Guiral V; Aznar J
    Clin Hemorheol Microcirc; 1997; 17(3):193-8. PubMed ID: 9356783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effect of alpha-blocker on hemorheology in patients with essential hypertension.
    Gomi T; Ikeda T; Ikegami F
    Am J Hypertens; 1997 Aug; 10(8):886-92. PubMed ID: 9270083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Ramipril and Isradipin on hemorheological profiles in patients with arterial hypertension.
    Muravyov AV; Zaitsev LG; Muravyov AA; Yakusevich VV; Sirotkina AM
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):185-90. PubMed ID: 9699040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood rheology in men with essential hypertension and capillary rarefaction.
    Ciuffetti G; Pasqualini L; Pirro M; Lombardini R; De Sio M; Schillaci G; Mannarino E
    J Hum Hypertens; 2002 Aug; 16(8):533-7. PubMed ID: 12149658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of an L- and N-type calcium channel blocker in hypertensive patients with neurovascular compression of the rostral ventrolateral medulla.
    Aota Y; Morimoto S; Sakuma T; Morita T; Jo F; Takahashi N; Maehara M; Ikeda K; Sawada S; Iwasaka T
    Hypertens Res; 2009 Aug; 32(8):700-5. PubMed ID: 19521420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcium antagonists in therapy of arterial hypertension].
    Brandt D
    Wien Med Wochenschr; 1993; 143(19-20):510-3. PubMed ID: 8135033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased blood viscosity and serum levels of erythropoietin after anti-hypertensive treatment with amlodipine or metoprolol: results of a cross-over study.
    Linde T; Sandhagen B; Hägg A; Mörlin C; Danielson BG
    J Hum Hypertens; 1996 Mar; 10(3):199-205. PubMed ID: 8733040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypertension and vascular diseases: molecular and cellular mechanisms].
    Lüscher TF
    Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemorheological and hemodynamic changes in predialysis patients after normalization of hemoglobin with epoetin-alpha.
    Furuland H; Linde T; Sandhagen B; Andrén B; Wikström B; Danielson BG
    Scand J Urol Nephrol; 2005; 39(5):399-404. PubMed ID: 16257842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic considerations and cellular mechanism related to calcium's antihypertensive effects.
    McCarron DA; Morris CD
    Fed Proc; 1986 Nov; 45(12):2734-8. PubMed ID: 3533638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
    Schiffrin EL
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1192-200. PubMed ID: 15607629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell fluidity in hypertension.
    Sandhagen B
    Clin Hemorheol Microcirc; 1999; 21(3-4):179-81. PubMed ID: 10711740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity?
    Moan A; Høieggen A; Nordby G; Eide IK; Kjeldsen SE
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S45-50. PubMed ID: 8583481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of calcium antagonists in the treatment of arterial hypertension].
    Velasco M; Negrín C
    Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil].
    Wacker J; Müller J; Grischke EM; Unkels R; Bastert G
    Zentralbl Gynakol; 1994; 116(5):271-3. PubMed ID: 8023622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertension and diabetes mellitus].
    Janka HU
    Z Gesamte Inn Med; 1993 Mar; 48(3):157-61. PubMed ID: 8475640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New evidence for involvement of blood rheological disorders in rise of peripheral resistance in essential hypertension.
    Mchedlishvili G; Tsinamdzvrishvili B; Beritashvili N; Gobejishvili L; Ilencko V
    Clin Hemorheol Microcirc; 1997; 17(1):31-9. PubMed ID: 9181756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.